Rich Habits on $LLY (Oct 30, 2026)
The speaker is long LLY with about $15,000, bought from $877 on March 29, 2026 and averaged; the position is up 38% versus the S&P's about 12% this year. He also notes LLY's upcoming GLP-1 drug beat Ozempic head-to-head.
Jump to any passage
Eli Lilly's upcoming GLP-1 drug has just outperformed Ozembeek in a head-to-head contest.
Man, I want to pause for a moment on that comment about Eli Lilly's retarotide drug . As you know, I just reviewed my financial position at Eli Lilly. I have about $15,000 in it.
Ah, I'm looking at my record. On March 29, 2026, I started buying at $877 per share and continued to average the dollar cost to the early nine hundred dollars per share. It is now up 38%, while the S&P index has risen by about 12% this year.
What this channel has said about $LLY
Rich Habits has 2 calls on this stock; only the adjacent ones are shown.